247 related articles for article (PubMed ID: 12723719)
1. Use of nephrostomy tubes in ureteric obstruction from incurable malignancy.
Little B; Ho KJ; Gawley S; Young M
Int J Clin Pract; 2003 Apr; 57(3):180-1. PubMed ID: 12723719
[TBL] [Abstract][Full Text] [Related]
2. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
[TBL] [Abstract][Full Text] [Related]
3. The role of percutaneous nephrostomy in malignant ureteric obstruction.
Wilson JR; Urwin GH; Stower MJ
Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in malignant ureteric obstruction.
Lienert A; Ing A; Mark S
BJU Int; 2009 Oct; 104(7):938-41. PubMed ID: 19338533
[TBL] [Abstract][Full Text] [Related]
5. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction.
Bell DG; Fischer MA
Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
[TBL] [Abstract][Full Text] [Related]
7. Complications of percutaneous nephrostomy in the treatment of malignant ureteral obstructions: single-centre review.
Carrafiello G; Laganà D; Mangini M; Lumia D; Recaldini C; Bacuzzi A; Marconi A; Mira A; Cuffari S; Fugazzola C
Radiol Med; 2006 Jun; 111(4):562-71. PubMed ID: 16779542
[TBL] [Abstract][Full Text] [Related]
8. [Endoluminal therapy for bilateral malignant ureteric obstruction].
Liu YD; Yuan J; Huang ST; Luo JT; Zeng GH; Xun L
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):717-9. PubMed ID: 18246808
[TBL] [Abstract][Full Text] [Related]
9. [Results of balloon nephrostomy in the treatment of lower urinary tract fistula].
Zairi A; Nohra J; Khedis M; Thoulouzan M; Otal P; Joffre F; Rischmann P; Plante P; Soulie M; Huyghe E
Prog Urol; 2008 Jun; 18(6):372-8. PubMed ID: 18558327
[TBL] [Abstract][Full Text] [Related]
10. [Endo-urological drainage in urinary outflow obstruction caused by cancer].
Stevens A; van Driel MF; Klein JP; de Ruiter AJ; Mensink HJ
Ned Tijdschr Geneeskd; 1994 Mar; 138(10):522-5. PubMed ID: 8139712
[TBL] [Abstract][Full Text] [Related]
11. Malignant ureteral obstruction: outcomes after intervention. Have things changed?
Wong LM; Cleeve LK; Milner AD; Pitman AG
J Urol; 2007 Jul; 178(1):178-83; discussion 183. PubMed ID: 17499300
[TBL] [Abstract][Full Text] [Related]
12. Predicting the success of retrograde stenting for managing ureteral obstruction.
Yossepowitch O; Lifshitz DA; Dekel Y; Gross M; Keidar DM; Neuman M; Livne PM; Baniel J
J Urol; 2001 Nov; 166(5):1746-9. PubMed ID: 11586215
[TBL] [Abstract][Full Text] [Related]
13. Clinical Factors Associated With a Short Survival Time After Percutaneous Nephrostomy for Ureteric Obstruction in Cancer Patients: An Updated Model.
Alawneh A; Tuqan W; Innabi A; Al-Nimer Y; Azzouqah O; Rimawi D; Taqash A; Elkhatib M; Klepstad P
J Pain Symptom Manage; 2016 Feb; 51(2):255-61. PubMed ID: 26497918
[TBL] [Abstract][Full Text] [Related]
14. Nephrostomy insertion for patients with bilateral ureteric obstruction caused by prostate cancer.
Nariculam J; Murphy DG; Jenner C; Sellars N; Gwyther S; Gordon SG; Swinn MJ
Br J Radiol; 2009 Jul; 82(979):571-6. PubMed ID: 19153185
[TBL] [Abstract][Full Text] [Related]
15. Obstructive uropathy in gynecologic malignancy. Detrimental effect of intraureteral stent placement and value of percutaneous nephrostomy.
Hyppolite JC; Daniels ID; Friedman EA
ASAIO J; 1995; 41(3):M318-23. PubMed ID: 8573816
[TBL] [Abstract][Full Text] [Related]
16. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous nephrostomy for ureteric obstruction due to advanced pelvic malignancy: have we got the balance right?
Misra S; Coker C; Richenberg J
Int Urol Nephrol; 2013 Jun; 45(3):627-32. PubMed ID: 23666587
[TBL] [Abstract][Full Text] [Related]
18. Nephrostomy in patients with ureteral obstruction secondary to nonurologic malignancy. Obstructive uropathy in malignant disease.
McNamara TE; Butkus DE
Arch Intern Med; 1980 Apr; 140(4):494-7. PubMed ID: 7362379
[TBL] [Abstract][Full Text] [Related]
19. [Middle-aged and elderly patients with hydronephrosis induced by ureteric obstruction: etiology and diagnosis].
Qu X; Hou S; Wang X; Huang X; Xu K; Yang C
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):531-3. PubMed ID: 11832102
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous urinary drainage and ureteric stenting in malignant disease.
Allen DJ; Longhorn SE; Philp T; Smith RD; Choong S
Clin Oncol (R Coll Radiol); 2010 Nov; 22(9):733-9. PubMed ID: 20728326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
